Accuray Inc (ARAY) will report its 2023 Q2 earnings on Wednesday, 01 February 2023, after market close. Wallstreet estimates an EPS of $-0.03 and a revenue of $107.03 M in the upcoming results. Historically, Accuray Inc beated EPS estimates 36% of the times.
About Accuray Inc
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. The company also provides the TomoTherapy System, including the Radixact System.